Valeo Financial Advisors LLC lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 159.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,221 shares of the exchange traded fund’s stock after buying an additional 11,822 shares during the period. Valeo Financial Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $3,031,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of XBI. Wealth Management Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the first quarter worth about $547,000. Keystone Investors PTE Ltd. acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at about $12,022,000. Continuum Advisory LLC increased its position in SPDR S&P Biotech ETF by 389.1% in the 2nd quarter. Continuum Advisory LLC now owns 18,013 shares of the exchange traded fund’s stock valued at $2,851,000 after acquiring an additional 14,330 shares during the period. Wellington Management Group LLP purchased a new stake in SPDR S&P Biotech ETF during the 2nd quarter valued at approximately $19,270,000. Finally, Jessup Wealth Management Inc acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $1,053,000.
SPDR S&P Biotech ETF Price Performance
Shares of XBI stock traded down $1.52 during midday trading on Thursday, hitting $148.71. The company had a trading volume of 9,089,923 shares, compared to its average volume of 9,128,042. The company’s 50 day simple moving average is $158.50 and its 200 day simple moving average is $145.70. SPDR S&P Biotech ETF has a 52-week low of $103.43 and a 52-week high of $169.89. The stock has a market cap of $9.72 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
- This Space ETF Offers SpaceX Exposure—But Investors Are Paying for the Volatilit
- Does Lemonade’s Growth Signal Profits Ahead?
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
